Delivery Order SPE2DB25D3022-SPE2DB25FWBBT
Award Date
4/7/25
Potential Completion Date
4/28/25
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,654.33, is for the delivery of PROQUAD VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 16, 2025. The contract was awarded on March 26, 2025, and has no set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $5,372.90 firm-fixed-price contract is for the delivery of "PROQUAD VIALS", a medical product, with a completion date of February 19, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,308.68, is for the delivery of PROQUAD VIALS, a medical product. It is a firm fixed-price delivery order contract with a period of performance through March 19, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,247.58 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a medical product. The contract has a completion date of December 26, 2024 and was awarded on December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,687.44, is for the supply of PROQUAD VIALS, a medical product, under a Firm Fixed Price contract type. The award has an Ultimate Completion Date of March 12, 2025 and was made on February 19, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,740.49, is for the delivery of PROQUAD VIALS, a type of medical product. It is a Firm Fixed Price, Delivery Order contract with an ultimate completion date of April 23, 2025. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is for the delivery of PROQUAD VIALS medical products. It is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,670.90, is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a completion date of May 19, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,271.65, is for the procurement of PROQUAD VIALS, a type of medical product. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,962.99, is for the delivery of PROQUAD VIALS, a medical product. The contract has a firm fixed price pricing type and a performance period ending on May 13, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...